Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Health dept. reviewing bird flu vaccine deal with Moderna: RPT
In This Article:
Moderna (MRNA) stock is reacting to reports of the US Department of Health and Human Services (HHS) reconsidering its bird flu vaccine deal with the drug maker.
Yahoo Finance senior health reporter Anjalee Khemlani sits down with the Catalysts team to review the details of the deal.
To watch more expert insights and analysis on the latest market action, check out more Catalysts here.
This post was written by Luke Carberry Mogan.
Related Videos
Terms and Privacy Policy